Mesenchymal stromal stem cell therapy in advanced interstitial lung disease - Anaphylaxis and short-term follow-up

There are limited treatment options for advanced interstitial lung disease (ILD). We describe a patient of ILD treated with mesenchymal stromal stem cell infusion. The index patient had end-stage ILD due to a combination of insults including treatment with radiotherapy and a tyrosine kinase inhibito...

Descripción completa

Detalles Bibliográficos
Autores principales: Thangakunam, Balamugesh, Christopher, Devasahayam Jesudas, Mathews, Vikram, Srivastava, Alok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587005/
https://www.ncbi.nlm.nih.gov/pubmed/26628765
http://dx.doi.org/10.4103/0970-2113.164156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587005/
https://www.ncbi.nlm.nih.gov/pubmed/26628765
http://dx.doi.org/10.4103/0970-2113.164156

Ejemplares similares